FDA clears testing for another gene-editing drug in humans
December 03, 2018 at 14:50 PM EST
The study, which Editas said will involve 10 to 20 patients, will be the second company-sponsored clinical trial in the U.S. of a drug based on CRISPR/Cas9 technology.
